1987
DOI: 10.1097/00004850-198707000-00005
|View full text |Cite
|
Sign up to set email alerts
|

Citalopram???A Highly Selective 5-HT Uptake Inhibitor???in the Treatment of Depressed Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
21
0

Year Published

1993
1993
2010
2010

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(22 citation statements)
references
References 0 publications
1
21
0
Order By: Relevance
“…Furthermore, a steady state of both citalopram and lithium was observed throughout the experiments. The steady states were found to be within the expected therapeutic windows [lithium 0.3-1.0 mM (Schou 1991); citalopram 154-524 nM (Dufour et al 1987)]. …”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, a steady state of both citalopram and lithium was observed throughout the experiments. The steady states were found to be within the expected therapeutic windows [lithium 0.3-1.0 mM (Schou 1991); citalopram 154-524 nM (Dufour et al 1987)]. …”
Section: Resultsmentioning
confidence: 99%
“…Patients receiving 30-60 mg/day exhibit mean plasma citalopram levels of 28-616 nM (Dufour et al 1987;Fredricson Overo 1982a;Pedersen et al 1982). We administered 10-30-mg/kg/day citalopram to mice since 24-mg/kg/day citalopram results in plasma levels toward the middle of this range in mice (383 nM; Honig et al 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Controlled clinical trials have demonstrated the superior efficacy of escitalopram over citalopram despite equivalent doses containing a corresponding number of S -CIT molecules in both drugs [1,5,8,18,19,25] . As a result, the interindividual and dosedependent variations of the enantiomer ratios may theoretically infl uence the clinical effi cacy of a given dose of racemic CIT in the individual due to the antagonistic role of the R -enantiomer [14,20] , which may further partially explain the inconsistent and confl icting data on the relationship between serum CIT and clinical response [7,8,22] .…”
Section: Discussion ▼mentioning
confidence: 99%
“…As a result, the interindividual and dosedependent variations of the enantiomer ratios may theoretically infl uence the clinical effi cacy of a given dose of racemic CIT in the individual due to the antagonistic role of the R -enantiomer [14,20] , which may further partially explain the inconsistent and confl icting data on the relationship between serum CIT and clinical response [7,8,22] . This hypothesis may gain further support by data showing that R -CIT attenuates the association rate of paroxetine to the serotonin transporter, potentially infl uencing its clinical effi cacy [9] .…”
Section: Discussion ▼mentioning
confidence: 99%